SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Pluristem Therapeutics
An SI Board Since September 2005
Posts SubjectMarks Bans Symbol
295 17 0 PSTI
Emcee:  FJB Type:  Moderated
Introduction Market Data Compact
Pluristem Life Systems, Inc. (OTCBB PLRS): aims to become a leader in stem cell expansion, specializing initially in hematopoietic stem cells, using its unique 3-D technology platform and proprietary PluriX™ bioreactor. Similarly, the Company will further develop its exclusive stromal cell expression libraries, which are expected to boost bone marrow transplants and significantly improve their success rate while maximizing immune system functioning.
Website pluristem.com
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
295Is anyone here still following PSTI. If so, you should know about the Phase 2 TGary Mohilner17/18/2020
294Pluristem Therapeutics’ CEO Issues Shareholder Letter HAIFA, Israel, July 02, 2FJB-7/2/2019
293PSTI reports positive top line results. PLX-PAD treatment reduced risk of revasACAN16/12/2018
292PSTI HAIFA, Israel, June 04, 2018 (GLOBE NEWSWIRE) -- Pluristem Therapeutics ACAN-6/4/2018
291PSTI April 30 FDA clears Pluristem radiation treatment for emergency use ByACAN14/30/2018
290PSTI chart looks to be responding well to latest news, and good volume setting uACAN-4/25/2018
289is there anyone out there that owns psti that would like to share or talk about thesaud-4/7/2018
288On watch for clear above 2.02. [graphic]hollyhunter-10/23/2017
287Securities and Exchange Commission v. Jason Napodano, Bilal Basrai and Bryce StiStockDung-9/27/2017
286PLX-R18 Heals 100% of Population Exposed To Lethal Radiation through Nuclear AccFJB-3/9/2016
285Bullish cross in MACD and Stochastic oscillator according to foxchart. On watch sfnsie-12/5/2015
284Israeli biotech firm to test radiation therapy in Fukushima JERUSALEM, Dec 3 (RFJB-12/3/2015
283DoneSI Ron (Crazy Music Man)-6/1/2015
282Did xcentral respond to this request? I will moderate if nobody responded...FJB-6/1/2015
281Pluristem Granted Key Cell Patents in Asia, Russia, Mexico, and Israel Company FJB-6/1/2015
280Does anyone want to moderate this board?SI Ron (Crazy Music Man)-1/28/2015
279New Published Data Show Pluristem's PLX Cells Protect Neurons PLX Cells CoFJB-1/2/2015
278Phase I/II trial in the treatment of muscle injury met primary safety & effidos21/21/2014
2779:29 am Pluristem Therapeutics: results of co's Phase I/II muscle injury triFJB-1/6/2014
276Positive Data From the First Study Prompts Decision HAIFA, Israel, Jul 18, 2013xcentral1-7/18/2013
275ps - IMHO - I think that the alliance with Cha in South Korea is "Brilliantxcentral1-7/11/2013
274Pluristem Completes Enrollment for Phase I/II Muscle Injury Trial Study Conducxcentral1-7/11/2013
273About that "Clinical-Hold" ... IMHO 1 - Aberman is dead serious abouxcentral1-7/9/2013
272Pluristem's South Korean Partner Files IND With Korean FDA for PLX Cells Hxcentral1-7/9/2013
271Pluristem Enters Into Strategic Partnership and Licensing Agreement With Cha Bioxcentral1-7/9/2013
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News